PubMed=15173000; DOI=10.1158/0008-5472.CAN-03-3149
Tina Pohle, Stephanie Ute Brandlein, Nele Ruoff, Hans-Konrad Muller-Hermelink, Heinz Peter Vollmers;
Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulation.
Cancer Res. 64:3900-3906(2004)

PubMed=17237291; DOI=10.1158/1535-7163.MCT-06-0399
Stephanie Ute Brandlein, Nicole Rauschert, Leo Rasche, Angela Dreykluft, Frank Hensel, Ernst Conzelmann, Hans-Konrad Muller-Hermelink, Heinz Peter Vollmers;
The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein.
Mol. Cancer Ther. 6:326-333(2007)

PubMed=18268478; DOI=10.1038/labinvest.2008.2
Nicole Rauschert, Stephanie Ute Brandlein, Elisabeth Holzinger, Frank Hensel, Hans-Konrad Muller-Hermelink, Heinz Peter Vollmers;
A new tumor-specific variant of GRP78 as target for antibody-based therapy.
Lab. Invest. 88:375-386(2008)

Patent=WO2009104100A2
Heinz Peter Vollmers, Frank Hensel, Barbara E. Power, Leodevico L. Ilag, Arndt-Rene Kelter, Frank Schoenen, Hans-Konrad Muller-Hermelink, Andreas Thalheimer, Lishanthi Udabage, Stephanie Ute Brandlein;
Antibody combinations, and methods of making and using same.
Patent number WO2009104100A2, 27-Aug-2009

Patent=US9273125
Heinz Peter Vollmers;
Human monoclonal antibody having fat-reducing effect.
Patent number US9273125, 01-Mar-2016